falloposcopy

falloposcopy

/fal·lo·pos·co·py/ (fah-lo-pos´kah-pe) endoscopic visualization of the uterine tubes using a nonincisional transvaginal and transuterine approach.

falloposcopy

(fă-lō-pos′kŏ-pē) [ fallop(ian tube) + -scopy]
Imaging the interior of the fallopian tube (the endosalpinx) with a flexible fiber-optic endoscope. The procedure is used in the diagnosis and treatment of tubal infertility.
References in periodicals archive ?
Gamete intra-fallopian transfer (GIFT) was accomplished by Porcu and Dal Prato through trans-cervical falloposcopy (78).
It complements the Company's current product line related to women's healthcare such as the MicroLap(R) micro-endoscopy system, Ovation(TM) falloposcopy system, MicroSpan(TM) hysteroscopy products and the EndoView(TM) family of medical video products for the less invasive gynecological market.
The Company has developed the STARRT Falloposcopy and T-TAC catheter systems to improve the diagnosis and treatment of fallopian tube diseases and disorders, a primary cause of infertility.
Falloposcopy, which is the study of the pathology of the fallopian tubes using a fiber-optic endoscope, is being evaluated in a twenty center, International Multicenter Study of Falloposcopy (IMSF), directed by Dr.
Falloposcopy Feasibility Trials to Move Forward Conceptus received prompt FDA approval on the company's IDE, submitted in April, for a feasibility study of its transcervical coaxial falloposcope system, a diagnostic device that allows the physician to evaluate fallopian tube pathology directly through the introduction of a small, flexible endoscope into the right and left oviducts.
The procedure, called falloposcopy, will be utilized at Methodist Hospital, located in the Twin Cities.
The Company has developed the STARRT(tm) Falloposcopy and T-TAC(tm) catheter systems to improve the diagnosis and treatment of fallopian tube diseases and disorders, a primary cause of infertility.
These products include the company's STARRT(TM) (Selective Tubal Assessment to Refine Reproductive Therapy) Falloposcopy System, an endoscopic product which utilizes Conceptus's proprietary T-TAC(TM) (Transcervical Tubal Access Catheter) technology to improve the diagnosis of infertility, and the ERA(TM) Resectoscope Sleeve, a novel device which is utilized with commercially available resectoscopes to improve the safety of several minimally invasive surgical alternatives to hysterectomy, such as endometrial ablation and myomectomy, in order to remove benign uterine pathology.
Having eliminated its sales and marketing organizations in the restructuring, Conceptus is seeking to outlicense or establish marketing relationships in order to distribute its current products, including the STARRT(tm) Falloposcopy system and the ERA(tm) and FUTURA(tm) Resectoscope Sleeves to the Interventional Gynecology market.
With this restructuring, we will seek marketing partners to distribute our current products, the ERA(TM) and FUTURA(TM) Resectoscope Sleeves and the STARRT(TM) Falloposcopy system.
During the quarter, Conceptus received clearance of a 510(k) from the United States Food and Drug Administration (FDA) for the Stargate(tm) catheter, a component of the Company's STARRT Falloposcopy System.
JMS will have exclusive rights to market Conceptus' complete line of infertility diagnostic products in Japan, including the Transcervical Tubal Access Catheter (T-TAC(TM)) System and the Selective Tubal Assessment to Refine Reproductive Therapy (STARRT(TM)) Falloposcopy System.